Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Glaukos (GKOS) EBT (2016 - 2026)

Glaukos has reported EBT over the past 13 years, most recently at -$19.3 million for Q1 2026.

  • Quarterly EBT fell 8.3% to -$19.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.1 million through Mar 2026, down 87.47% year-over-year, with the annual reading at $4.6 million for FY2025, 106.29% up from the prior year.
  • EBT was -$19.3 million for Q1 2026 at Glaukos, down from $57.8 million in the prior quarter.
  • Over five years, EBT peaked at $114.1 million in Q4 2024 and troughed at -$50.2 million in Q2 2024.
  • The 5-year median for EBT is -$19.4 million (2025), against an average of -$300764.7.
  • Year-over-year, EBT soared 388.25% in 2022 and then plummeted 700.12% in 2023.
  • A 5-year view of EBT shows it stood at $70.2 million in 2022, then surged by 44.66% to $101.5 million in 2023, then rose by 12.46% to $114.1 million in 2024, then plummeted by 49.34% to $57.8 million in 2025, then tumbled by 133.38% to -$19.3 million in 2026.
  • Per Business Quant, the three most recent readings for GKOS's EBT are -$19.3 million (Q1 2026), $57.8 million (Q4 2025), and -$16.0 million (Q3 2025).